市場調查報告書

白血球分離療法市場:成長,趨勢,及預測

Leukapheresis Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921996
出版日期 內容資訊 英文 113 Pages
商品交期: 2-3個工作天內
價格
白血球分離療法市場:成長,趨勢,及預測 Leukapheresis Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 113 Pages
簡介

本報告提供白血球分離療法市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,類型·用途·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 白血病的盛行率增加
    • 臨床研究活動中白血球的需求增加
  • 市場阻礙因素
    • 成本高的治療性白血球分離術
    • 募集捐贈者的嚴格法規問題
  • 波特的五力分析

第5章 市場區隔

  • 各類型
    • 白血球分離設備
    • 白血球去除術
  • 各用途
    • 治療
    • 研究
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Terumo BCT Inc
    • 旭化成醫學株式會社
    • Fresenius SE & Co. KGaA
    • Haemonetics Corporation
    • Macopharma
    • Key Biologics LLC
    • Precision Medicine Group, LLC
    • STEMCELL Technologies Inc
    • StemExpress
    • BioIVT LLC

第7章 市場機會及今後趨勢

目錄
Product Code: 67774

Market Overview

The Leukapheresis Market is expected to grow with a CAGR of 7.5%, during the forecast period. Leukapheresis is a laboratory procedure in which white blood cells including leukemia cells are separated from a sample of blood. Leukemia is a different type of cancer from most of the other cancers that start in the bone marrow where new blood cells are made. Leukemia starts in early forms of blood cells, usually white blood cells or leucocytes, which helps to fight against infections caused by foreign particles. People with leukemia, produce too many blood cells, and they aren't normal they travel in the blood and go all over the body and cause problems depending upon the organs involved. The incidence of leukemia is highest among whites and lowest among Chinese, Japanese, and Koreans in both men and women and the highest among men than women. Some of the signs and symptoms of leukemia are fatigue and weakness, bleeding from gums, trauma, bruising, fever, weight loss, etc. According to International Agency for Research on Cancer (IARC), in the year 2018 number of leukemia cases for both sexes were estimated as 437,033 cases of leukemia (2.6%), in men 249,454 cases of leukemia (2.8%), in women 187,579 cases of leukemia (2.3%) globally. Rising incidence and prevalence of leukemia and growing demand for leukapheresis procedures are the key driving factors in the leukapheresis market.

Scope of the Report

Leukapheresis is a laboratory procedure in which white blood cells including leukemia cells are separated from the blood. Leukapheresis is segmented by Type (Leukapheresis Devices (Apheresis Devices, Leukapheresis Columns, and Cell Separators, Leukoreduction Filters), Leukapheresis Disposables), Application and Geography.

Key Market Trends

Leukapheresis Disposables Segment is Expected to Hold a Major Market Share in the Leukapheresis

  • Rising applications of leukapheresis procedures for the isolation of white blood cells (WBCs) or leukocytes or leucocytes, from the blood for cell therapy research applications and repeated consumption of disposables in leukapheresis procedures, is estimated to drive the growth of the leukapheresis disposables segment.
  • According to International Agency for Research on Cancer (IARC), in the year 2018 number of leukemia cases for both sexes are estimated as 437,033 cases of leukemia (2.6%), in men 249,454 cases of leukemia (2.6%), in women 187,579 cases of leukemia (2.3%) globally.
  • In the years 2017-2018, the Leukapheresis disposables segment holds a significant share in the market and is expected to grow significantly over the forecast period.
  • Increasing the prevalence of leukemia and growing demand for leukapheresis disposables are the key driving factors in the leukapheresis disposables segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America expected to hold the largest market share in the global leukapheresis market due to a rise in the geriatric population, increasing prevalence and incidence of leukemia in this region. According to the Leukemia and Lymphoma Society (LLS), in the year 2019, approximately 61,780 people were expected to be diagnosed with leukemia. According to the Leukemia and Lymphoma Society and American Cancer Society, from 2011-2015, in the United States leukemia was the sixth most common cause of cancer deaths in both men and women. Moreover, increasing clinical research activities and a larger presence of biotech and pharma companies is fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The Leukapheresis Market is consolidated competitive and consists of a few major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Asahi Kasei Medical Co. Ltd, Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc., Macopharma, Fresenius SE & Co. KGaA, HemaCare, Key Biologics LLC, AllCells, StemExpress.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Leukemia
    • 4.2.2 Growing Demand For Leukopaks in Clinical Research Activities
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Therapeutic Leukapheresis
    • 4.3.2 Stringent Regulatory Issues for Donor Recruitment
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Leukapheresis Devices
      • 5.1.1.1 Apheresis Devices
      • 5.1.1.2 Leukapheresis Columns and Cell Separators
      • 5.1.1.3 Leukoreduction Filters
    • 5.1.2 Leukapheresis Disposables
  • 5.2 By Application
    • 5.2.1 Therapeutic Applications
    • 5.2.2 Research Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Terumo BCT Inc
    • 6.1.2 Asahi Kasei Medical Co. Ltd
    • 6.1.3 Fresenius SE & Co. KGaA
    • 6.1.4 Haemonetics Corporation
    • 6.1.5 Macopharma
    • 6.1.6 Key Biologics LLC
    • 6.1.7 Precision Medicine Group, LLC
    • 6.1.8 STEMCELL Technologies Inc
    • 6.1.9 StemExpress
    • 6.1.10 BioIVT LLC

7 MARKET OPPORTUNITIES AND FUTURE TRENDS